Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-20-003571
Filing Date
2020-02-13
Accepted
2020-02-13 16:11:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G sc13g0220a4nineteen77_protal.htm SC 13G/A 29827
  Complete submission text file 0001213900-20-003571.txt   31664
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 20610619
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 NORTH WACKER CHICAGO IL 60606
Business Address 1 NORTH WACKER CHICAGO IL 60606 312-525-6064
Nineteen77 Global Multi-Strategy Alpha Master Ltd (Filed by) CIK: 0001698095 (see all company filings)

EIN.: 980227879 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A